Public preview. Funding rounds, founders, and growth signals require a free account.

Elgia Therapeutics, Inc.

Elgia Therapeutics discovers and develops small molecule drugs targeting metabolic inflammation and fibrosis by identifying novel protein targets implicated in chronic diseases. The company combines biological research insights with drug development expertise to create first-in-class and best-in-class therapeutics focused on caspase and kinase molecular pathways.

SeedPharmaSan Diego, CA1-10 employees

Total raised

$2.3M

Last round

Equity

$2.3M · Apr 2020

Stage

Seed

Status

Active

Founders & team

Co-founder, CEO

Co-founder, CTO

Head of Engineering

Head of Sales

🔒

Sign up to see founders

Free account unlocks founder names, LinkedIn profiles, and prior companies.

Create free account

Growth signals

Web traffic

Search interest

Social followers

Glassdoor rating

News mentions

Gov contracts

🔒

Sign up to see signals

Free account unlocks 5 full profiles per day. Pro removes the limit.

Create free account

Track Elgia Therapeutics, Inc. on FlareSight

Get notified the moment Elgia Therapeutics, Inc. files a new round, hires execs, or shows traction signals.

Create free account

About this data

FlareSight surfaces funding data from SEC Form D filings within hours of submission. Browse our full startup funding database to find more recently funded companies.